Strategic Gene Inactivation for Industrial Cell Factory Optimization. Aspergillus niger is a premier industrial workhorse, utilized globally for the production of organic acids, food-grade enzymes, and secondary metabolites. However, competing metabolic pathways and regulatory bottlenecks often limit production efficiency. CD Biosynsis provides professional Aspergillus niger Gene Knockout Services, utilizing advanced CRISPR-Cas9 and CRISPRi platforms. Our service enables the precise, permanent, or inducible silencing of target genes to eliminate metabolic shunts, enhance protein stability, and deconstruct complex regulatory networks.
Get a Technical QuoteOur gene knockout platform is tailored to the unique genomic landscape of filamentous fungi, supporting applications across pharmaceutical manufacturing, enzyme engineering, and agricultural research. We focus on eliminating metabolic bottlenecks to maximize strain performance.
| Service Tier | Technical Focus | Primary Application | Industrial/Research Value |
|---|---|---|---|
| Marker-Free CRISPR KO | Permanent biallelic disruption | Metabolic flux redirection | Eliminates unwanted byproducts |
| CRISPRi Gene Silencing | Transcriptional repression (dCas9) | Essential gene study & Tuning | Reversible control of vital pathways |
| Protease-Deficient Strains | Targeted secretion optimization | Industrial enzyme production | Prevents target protein degradation |
| Multiplex Gene Knockout | Simultaneous genomic rewiring | Complex pathway reconstruction | Rapidly removes gene families |
| Virulence Factor Disruption | Pathogenicity attenuation | Plant pathology & Bio-safety | Creates safer industrial strains |
1. Target Analysis
2. Editor Assembly
3. Transformation
4. Phenotypic Screening
Bioinformatic evaluation of target loci to design optimal gRNAs, ensuring high specificity in the fungal genome.
Project feasibility assessment and Mutual NDA signing.
Construction of fungal-specific CRISPR expression vectors or in vitro assembly of Cas9-RNP complexes for marker-free editing.
Verification of nuclease activity prior to fungal delivery.
Delivery of knockout machinery via protoplast-mediated transformation or biolistic methods optimized for Aspergillus.
Strict aseptic processing to maintain strain purity and viability.
Identification of mutants through selective growth and PCR/sequencing, followed by phenotypic characterization.
Final delivery of homokaryotic mutant strains and detailed characterization dossiers.
We benchmark our gene inactivation efficiency against landmark filamentous fungi research.
Understanding fungal growth drivers is essential for fermentation. Technical benchmarks have demonstrated CRISPRi-mediated silencing of the Dac1 gene. Silencing this target led to restricted growth and lack of conidia when using GlcNAc as a carbon source, revealing critical roles in carbon metabolism and growth phase engineering.
(Reference: Yu et al., 2022)
Endogenous proteases are a major bottleneck in secretion. Recent projects utilized CRISPR-Cas9 to knockout protease genes that traditionally degrade target proteins. By eliminating these metabolic traps and optimizing fermentation, researchers achieved significant increases in lipase activity, proving the effectiveness of knockout for enzyme stabilization.
(Reference: Aspergillus niger Enzyme Engineering, 2025)
In plant pathology, gene knockout investigates fungal virulence. By constructing mutants with virulence-related genes knocked out, researchers observed a significant decrease in the strain's ability to infect plants. This underscores the potential of knockout to weaken pathogenic traits for biological control and environmental safety.
(Reference: Tawfik et al., 2022)
Ready to eliminate metabolic bottlenecks in your industrial strains?
Contact Us1. How does CRISPR knockout differ from traditional recombination in Aspergillus?
Traditional methods are slow and require large homology arms. CRISPR is faster, more precise, and allows for simultaneous knockout of multiple genes without leaving selection markers behind.
2. Can you perform knockouts in proprietary industrial strains?
Yes. We can adapt our transformation and editing protocols to various industrial lineages, including those optimized for citric acid or glucoamylase production.
3. Is CRISPRi better than a permanent knockout?
CRISPRi is ideal for studying essential genes where a permanent deletion would be lethal. It allows for "tunable" silencing, useful for optimizing growth-related pathways.
4. How do you ensure the homokaryotic status of the final strain?
We perform multiple rounds of single-spore isolation and verification via PCR and sequencing to ensure every nucleus carries the intended modification.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.